Third Harmonic Bio is a clinical-stage biopharmaceutical company focused on the development of medicine for the treatment of allergic and inflammatory diseases. Its lead product candidate, THB001, is an oral small molecule inhibitor of KIT, a cell surface receptor that acts as the master survival and functional regulator of mast cells.